Celltrion
068270.KS
#770
Rank
$25.73 B
Marketcap
$124.26
Share price
1.34%
Change (1 day)
-5.33%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: $25.73 Billion USD

As of November 2024 Celltrion has a market cap of $25.73 Billion USD. This makes Celltrion the world's 770th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2024

End of year Market Cap

Year Marketcap Change
2024$25.73 B-23.13%
2023$33.48 B84.67%
2022$18.13 B-21.81%
2021$23.18 B-48.58%
2020$45.09 B126.46%
2019$19.91 B-19.83%
2018$24.83 B-3.51%
2017$25.74 B136.78%
2016$10.87 B34.5%
2015$8.08 B123.17%
2014$3.62 B1.53%
2013$3.56 B-17.91%
2012$4.34 B19%
2011$3.65 B5.92%
2010$3.44 B161.41%
2009$1.31 B63.51%
2008$0.80 B4217.29%
2007$18.68 M

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of Celltrion was reported to be:

$25.36 Billion USD
by Yahoo Finance info icon info icon
$25.36 Billion USD
by CompaniesMarketCap info icon info icon